LCTX Lineage Cell Therapeutics, Inc.
$0.84
Lineage Cell Therapeutics, Inc. (LCTX) Earnings News
Earnings press releases, previews and reviews for Lineage Cell Therapeutics, Inc. (LCTX), newest first. Our most recent is review: Lineage Cell Therapeutics Misses as Revenue Slides; HUNT1 Deal Trades a Quarter of Cash Runway for a Third Clinical Asset.
Thursday
November 12, 2026
6:50 PM ET
Lineage Cell Therapeutics Misses as Revenue Slides; HUNT1 Deal Trades a Quarter of Cash Runway for a Third Clinical Asset
Earnings Whispers · Review
Thursday
November 12, 2026
4:05 PM ET
Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Sunday
November 8, 2026
12:15 AM ET
Lineage Cell's Revenue Bar Looks Ambitious as Pipeline Promises Face a Year-End Test
Earnings Whispers · Preview
Thursday
November 5, 2026
8:00 AM ET
Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Thursday
October 29, 2026
8:00 AM ET
Lineage Provides Update on ReSonance® Program for Hearing Loss
Thursday
August 6, 2026
4:01 PM ET
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Thursday
July 30, 2026
8:00 AM ET
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026